1. Home
  2. PMN vs GYRO Comparison

PMN vs GYRO Comparison

Compare PMN & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMN
  • GYRO
  • Stock Information
  • Founded
  • PMN 2004
  • GYRO 1946
  • Country
  • PMN Canada
  • GYRO United States
  • Employees
  • PMN N/A
  • GYRO N/A
  • Industry
  • PMN Pharmaceuticals and Biotechnology
  • GYRO Building operators
  • Sector
  • PMN Health Care
  • GYRO Real Estate
  • Exchange
  • PMN Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • PMN 18.8M
  • GYRO 19.3M
  • IPO Year
  • PMN N/A
  • GYRO N/A
  • Fundamental
  • Price
  • PMN $0.59
  • GYRO $7.93
  • Analyst Decision
  • PMN Strong Buy
  • GYRO
  • Analyst Count
  • PMN 1
  • GYRO 0
  • Target Price
  • PMN $6.00
  • GYRO N/A
  • AVG Volume (30 Days)
  • PMN 37.4K
  • GYRO 932.0
  • Earning Date
  • PMN 05-13-2025
  • GYRO 01-01-0001
  • Dividend Yield
  • PMN N/A
  • GYRO N/A
  • EPS Growth
  • PMN N/A
  • GYRO N/A
  • EPS
  • PMN 0.11
  • GYRO N/A
  • Revenue
  • PMN N/A
  • GYRO $2,738,019.00
  • Revenue This Year
  • PMN N/A
  • GYRO N/A
  • Revenue Next Year
  • PMN N/A
  • GYRO N/A
  • P/E Ratio
  • PMN $5.68
  • GYRO N/A
  • Revenue Growth
  • PMN N/A
  • GYRO N/A
  • 52 Week Low
  • PMN $0.51
  • GYRO $6.80
  • 52 Week High
  • PMN $2.37
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • PMN 43.65
  • GYRO 39.32
  • Support Level
  • PMN $0.51
  • GYRO $6.80
  • Resistance Level
  • PMN $0.65
  • GYRO $8.39
  • Average True Range (ATR)
  • PMN 0.09
  • GYRO 0.17
  • MACD
  • PMN 0.01
  • GYRO 0.04
  • Stochastic Oscillator
  • PMN 32.58
  • GYRO 64.94

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: